Isocitrate dehydrogenase type 1 (IDH1) mutation has been observed in 6–16% of adult patients with AML and is frequently associated with NPM1, DNTM3A, and FLT3-ITD mutations, an association that leads to inferior outcome [65]. The gene discussed is NPM1; the disease is acute myeloid leukemia.